CDC warns hospitals about drug-resistant 'superbug'
Government officials want the nation's health care providers to step up efforts to halt the spread of a drug-resistant "nightmare bacteria" that attacks the bloodstream and kills up to half of patients who become infected. In the first half of 2012, nearly 200 hospitals and acute care facilities treated at least one patient for the lethal "superbug" known as CRE, according to new data from the U.S. Centers for Disease Control and Prevention. Dr. Tom Frieden, director of the CDC, called CRE a "nightmare bacteria" because of its high mortality rate, its resistance to nearly all antibiotics and its ability to spread its drug resistance to other bacteria that otherwise would be vulnerable to vaccines.
- RN Named Chief Patient Experience Officer
- No Employee Satisfaction, No Patient-Centered Culture
- How Simple Data Analytics is Driving Physician Incentives
- AMA Pushes Lame Duck Congress for SGR Repeal
- Medicare to Finally Pay Doctors for Care They Were Giving Away
- As Retail Clinics Surge, Quality Metrics MIA
- Medicare Cost, Quality Data Tools Weak, Says GAO
- Quality in Ambulatory Surgical Settings Gets a Closer Look
- How Payers Are Curbing Behavioral-Health Cost Drivers
- Population Health Pays Off for NY Collaborative